A Randomized, Open Label, Single Dose, 2X2 Cross-over Study to Compare Pharmacokinetics Between Rosuvastatin 10mg and Omega-3 1g Co-administration and HCP1007 in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Omgea-3 fatty acid/rosuvastatin (Primary) ; Omega-3-acid ethyl esters; Rosuvastatin
Indications Lipid metabolism disorders
Focus Pharmacokinetics

01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
06 Jun 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000435).
19 Mar 2012 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com